Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
To learn if obinutuzumab in combination with CC-99282 can help to control previously untreated, high tumor burden FL
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznaniem chłoniaka mieszkowego (stopień 1-3a)
- •Brak wcześniejszego leczenia systemowego raka krwi
- •Zaawansowana choroba (stopień II, III lub IV)
- •Wiek 18 lat lub więcej
- •Duża masa guza (rozległa choroba o różnych objawach)
- •Guzki powiększone powyżej 7 cm lub wiele guzków powiększonych
- •Badania obrazowe potwierdzające mierzalną chorobę
- •Wystarczająca funkcja wątroby, nerek i liczby komórek krwi
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 31, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
M D Anderson Cancer Center
Houston, United States
Trial contact
Dai Chihara, M D, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.